168 related articles for article (PubMed ID: 6335868)
1. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
Chan JS; Gaspar L; Iguchi H; Seidah NG; Ling N; Chrétien M
Clin Invest Med; 1984; 7(4):205-8. PubMed ID: 6335868
[TBL] [Abstract][Full Text] [Related]
2. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome.
Gaspar L; Chan JS; Seidah NG; Chrétien M
Clin Invest Med; 1985; 8(2):167-75. PubMed ID: 3009068
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
Chan JS; Lu CL; Seidah NG; Chretien M
Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
[TBL] [Abstract][Full Text] [Related]
4. Ovine anterior pituitary proopiomelanocortin gene expression is not increased by ACTH secretagogues in vitro.
Levin N; Wallace C; Bengani N; Blum M; Farnworth P; Smith AI; Roberts JL
Endocrinology; 1993 Apr; 132(4):1692-700. PubMed ID: 8384993
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
Willemse T; Mol JA
Am J Vet Res; 1994 Dec; 55(12):1677-81. PubMed ID: 7887510
[TBL] [Abstract][Full Text] [Related]
6. Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro.
Suda T; Tozawa F; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
J Clin Invest; 1988 Jul; 82(1):110-4. PubMed ID: 2839542
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
8. Effects of vasopressin and elimination of corticotropin-releasing hormone-target cells on pro-opiomelanocortin mRNA levels and adrenocorticotropin secretion in ovine anterior pituitary cells.
van de Pavert SA; Clarke IJ; Rao A; Vrana KE; Schwartz J
J Endocrinol; 1997 Jul; 154(1):139-47. PubMed ID: 9246948
[TBL] [Abstract][Full Text] [Related]
9. Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary.
Levin N; Blum M; Roberts JL
Endocrinology; 1989 Dec; 125(6):2957-66. PubMed ID: 2555132
[TBL] [Abstract][Full Text] [Related]
10. Effects of various neuropeptides on the secretion of proopiomelanocortin-derived peptides by a cultured pituitary adenoma causing Nelson's syndrome.
Shibasaki T; Masui H
J Clin Endocrinol Metab; 1982 Nov; 55(5):872-6. PubMed ID: 6126487
[TBL] [Abstract][Full Text] [Related]
11. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies.
Familari M; Smith AI; Smith R; Funder JW
Neuroendocrinology; 1989 Aug; 50(2):152-7. PubMed ID: 2550836
[TBL] [Abstract][Full Text] [Related]
12. Ovine corticotrophin releasing factor stimulates ACTH release from human corticotrophinoma cells in culture; interaction with hydrocortisone and arginine vasopressin.
White MC; Adams EF; Loizou M; Mashiter K; Fahlbusch R
Clin Endocrinol (Oxf); 1985 Sep; 23(3):295-302. PubMed ID: 3000651
[TBL] [Abstract][Full Text] [Related]
13. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
Oosterom R; Verleun T; Uitterlinden P; Hackeng WH; Burbach JP; Wiegant VM; Lamberts SW
Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
[TBL] [Abstract][Full Text] [Related]
15. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
Livesey JH; Donald RA; Irvine CH; Redekopp C; Alexander SL
Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor and vasopressin production in the rat pituitary tumor 7315a: biochemical and immunohistochemical studies.
Morano MI; Estivariz FE
Cancer Res; 1989 May; 49(10):2755-60. PubMed ID: 2540907
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
[TBL] [Abstract][Full Text] [Related]
18. Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. II. Evidence for in vivo ultradian hypersecretion of proopiomelanocortin peptides by the isolated anterior and intermediate pituitary.
Engler D; Pham T; Liu JP; Fullerton MJ; Clarke IJ; Funder JW
Endocrinology; 1990 Oct; 127(4):1956-66. PubMed ID: 1976094
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the expression and secretion of urocortin 2 in rat pituitary.
Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T
J Endocrinol; 2007 Feb; 192(2):443-52. PubMed ID: 17283244
[TBL] [Abstract][Full Text] [Related]
20. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor.
DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Alexander AN; Vale W; Rivier J; Orth DN
J Clin Invest; 1984 Feb; 73(2):533-8. PubMed ID: 6321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
